Related Experiment Video
Updated: Jul 12, 2026
09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Advancing microfluidic point-of-care platelet function tests: opportunities and challenges from bench to market.
Minki Kang1, Christopher A Bresette1, David N Ku1
1George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, United States.
Frontiers in Bioengineering and Biotechnology
|December 31, 2024
Summary
Point-of-care platelet function tests (POC PFTs) using microfluidics offer rapid assessment of shear-induced platelet aggregation (SIPA). Current tests need improvement to accurately diagnose SIPA-related conditions for better patient outcomes.
Area of Science:
- Biomedical Engineering
- Hematology
- Medical Diagnostics
Background:
- Platelets are vital for hemostasis, and shear-induced platelet aggregation (SIPA) is crucial for blood clotting.
- Dysfunctional SIPA contributes to life-threatening conditions like hemorrhage and myocardial infarction.
- Point-of-care platelet function tests (POC PFTs) aim to assess platelet activity at the bedside.
Purpose of the Study:
- To review the current state of microfluidic-based POC PFTs for SIPA assessment.
- To identify challenges hindering the clinical application of these advanced diagnostic tools.
- To explore future opportunities for improving POC PFT technology.
Main Methods:
- Review of existing literature on microfluidic POC PFTs.
- Analysis of technological limitations in replicating in vitro high-shear conditions.
- Discussion of device design and manufacturing scalability.
Main Results:
- Microfluidic technology enhances POC PFTs, offering faster and more accurate results with minimal blood samples.
- Existing POC PFTs struggle to replicate the high-shear environments crucial for SIPA diagnosis.
- Device design and scalable manufacturing are key to clinical adoption.
Conclusions:
- Microfluidic POC PFTs hold significant promise for diagnosing SIPA-related disorders.
- Overcoming current technological and manufacturing hurdles is essential for widespread clinical use.
- Improved POC PFTs will lead to better patient management and outcomes.
